MARIA CLARA
ALVAREZ VILLAMARIN
University professor
University of Milan
Milán, ItaliaPublications in collaboration with researchers from University of Milan (6)
2024
-
Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)
Nature Communications
-
Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)
Nature Communications
-
Improved guidance is needed to optimise diagnostics and treatment of patients with thyroid cancer in Europe
Endocrine, Vol. 83, Núm. 3, pp. 585-593
-
dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe
Nature Communications, Vol. 15, Núm. 1
2022
-
Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
Healthcare (Switzerland), Vol. 10, Núm. 9
2017
-
Rewiring of the apoptotic TGF-β-SMAD/NFκB pathway through an oncogenic function of p27 in human papillary thyroid cancer
Oncogene, Vol. 36, Núm. 5, pp. 652-666